Lipocine Hit By Investor With Testosterone Drug 'Scheme' Suit
Specialty pharmaceutical company Lipocine Inc. and some of its officers were hit with a derivative suit in Delaware Chancery Court over claims they engaged in a "scheme" to mislead investors by...To view the full article, register now.
Already a subscriber? Click here to view full article